| Role of the mammalian target of rapamycin pathway in liver cancer: from molecular genetics to targeted therapies X Lu, P Paliogiannis, DF Calvisi, X Chen Hepatology 73, 49-61, 2021 | 112 | 2021 |
| Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma R Shang, X Song, P Wang, Y Zhou, X Lu, J Wang, M Xu, X Chen, ... Gut 70 (9), 1746-1757, 2021 | 93 | 2021 |
| Pretransplant use of immune checkpoint inhibitors for hepatocellular carcinoma: A multicenter, retrospective cohort study Z Guo, Y Liu, Q Ling, L Xu, T Wang, J Zhu, Y Lin, X Lu, W Qu, F Zhang, ... American Journal of Transplantation, 2024 | 17 | 2024 |
| Combined treatment with MEK and mTOR inhibitors is effective in in vitro and in vivo models of hepatocellular carcinoma X Liu, J Hu, X Song, K Utpatel, Y Zhang, P Wang, X Lu, J Zhang, M Xu, ... Cancers 11 (7), 930, 2019 | 16 | 2019 |
| Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer Y Chen, Y Liu, S Chen, L Zhang, J Rao, X Lu, Y Ma Frontiers in Immunology 14, 1180184, 2023 | 15 | 2023 |
| Yap accelerates notch-driven cholangiocarcinogenesis via mtorc1 in mice X Lu, B Peng, G Chen, MG Pes, S Ribback, C Ament, H Xu, R Pal, ... The American Journal of Pathology 191 (9), 1651-1667, 2021 | 15 | 2021 |
| Dendritic cells transduced with single immunoglobulin IL-1-related receptor exhibit immature properties and prolong islet allograft survival Z Xue, X Zhang, M Chen, X Lu, R Deng, Y Ma Frontiers in Immunology 8, 1671, 2017 | 15 | 2017 |
| Combination of AFP vaccine and immune checkpoint inhibitors slows hepatocellular carcinoma progression in preclinical models X Lu, S Deng, J Xu, BL Green, H Zhang, G Cui, Y Zhou, Y Zhang, H Xu, ... The Journal of Clinical Investigation 133 (11), 2023 | 12 | 2023 |
| Towards a New 3Rs Era in the construction of 3D cell culture models simulating tumor microenvironment L Zhang, W Liao, S Chen, Y Chen, P Cheng, X Lu, Y Ma Frontiers in Oncology 13, 1146477, 2023 | 10 | 2023 |
| Dendritic cells that highly express SOCS1 induce T-cell hypo-responsiveness and prolong islet allograft survival X Lu, M Chen, Z Xue, X Zhang, J Xu, L Wu, R Deng, Y Ma Cellular Immunology 314, 36-41, 2017 | 10 | 2017 |
| Preclinical and clinical studies of immunotherapy for the treatment of cholangiocarcinoma X Lu, BL Green, C Xie, C Liu, X Chen JHEP Reports 5 (7), 100723, 2023 | 6 | 2023 |
| Oleic acid-PPARγ-FABP4 loop fuels cholangiocarcinoma colonization in lymph node metastases microenvironment H Zhang, K Zhu, R Zhang, Y Guo, J Wang, C Liu, X Lu, Z Zhou, W Wu, ... Hepatology 80 (1), 69-86, 2024 | 4 | 2024 |
| Overexpression of TBX3 suppresses tumorigenesis in experimental and human cholangiocarcinoma S Deng, X Lu, X Wang, B Liang, H Xu, D Yang, G Cui, A Yonemura, ... Cell Death & Disease 15 (6), 441, 2024 | 2 | 2024 |
| A modified method for isolating mouse islets of an adequate quality, quantity, and purity J Xu, B Peng, C Zhang, J Xu, Y Ma, X Lu Biochemistry and Cell Biology 95 (4), 455-458, 2017 | 1 | 2017 |
| MAD2L1 supports MYC-driven liver carcinogenesis in mice and predicts poor prognosis in human hepatocarcinoma X Lu, Y Zhang, J Xue, M Evert, D Calvisi, X Chen, X Wang Toxicological Sciences 203 (1), 41-51, 2025 | | 2025 |
| Pretransplant immunotherapy increases acute rejection yet improves survival outcome of HCC patients with MVI post-liver transplantation X Lu, Q Zhu, J Cai, Z Yang, G Gu, L Pang, M Su, F Zhang, H Lin, W Wu, ... Cancer Immunology, Immunotherapy 74 (1), 18, 2024 | | 2024 |
| Short-Term Prognosis of Recipients with Pretransplant Exposure to Immune Checkpoint Inhibitors after Liver Transplantation for Hepatocellular Carcinoma: a Comparative … L Pang, LB Xu, Z Chen, Y Liu, T Ding, YF Ye, X Lu, G Gu, H Lin, WR Wu, ... Available at SSRN 4915294, 0 | | |
